21 May 2009
Factors predisposing to urinary tract infections in adult kidney allograft recipients with urinary tract reconstruction
J Pazik, E Ważna, Z Lewandowski, A Chmura, S Nazarewski, M DurlikAnn Transplant 2009; 14(1): 73-74 :: ID: 880470
Abstract
Background: Urinary bladder augmentation or urinary diversion may be necessary for successful kidney transplantation in patients with serious lower urinary tract abnormalities. Reconstruction of urine collecting system may be performed either prior to or at the time of transplantation. Urinary tract infections (UTI) are common in this subset of patients and potentially threatening to graft survival. Aim of the study: To evaluate risk factors of serious, recurrent urinary tract infections (defined as more than one UTI episode requiring hospitalization or urosepsis) in patient with simultaneous to engraftment ileal conduit operation or two-stage surgical protocol.
Material/Methods: In retrospective analysis we identified 24 adult kidney
recipients transplanted between 1999-2008 with severe lower urinary tract
abnormalities requiring reconstruction. In 14 patients ileal loop was created at engraftment, in 7 prior to procedure; 2 patients had continent urine reservoir with Mitrofanoff fistula, 2 bladder augmentation, one cutaneous ureterostomy.
Results: Mean post-transplant follow-up was 33.6±28 month, kidney allograft survival excellent - 97%, and serum creatinine 1.29±0.42 (range 0.9-2.6) mg/dl at the end of observation. Two patients lost their grafts - one kidney was removed because of recurrent bacterial and fungal sepsis, other patient reentered dialysis because of recurrent pyelonephritis. 88% (n=21) of patients had at least one episode of urinary tract infection and 67% (n=16) of them
required in-hospital care. In control group (matched in 1: 3 ration for engraftment date, recipient age and gender) UTI incidence was significantly lower, 44% (n=30), p<0.001. We evaluated the relation between listed parameters and the risk of UTI: recipient gender, living vs. deceased donor, CMV disease, chronic hepatitis, quadruple immunosuppressive regiment, acute rejection episodes, simultaneous with transplantation vs. two stage procedure. The only parameter associated with significantly increased UTI risk was CMV decease (HR 5.9-10, p<0.02
Conclusions: Collecting system reconstruction increases the risk of urinary tract infections (UTI in kidney allograft recipients. We couldn't identify additional, potentially modifiable risk factors of infectious complications. As recipients with urine collecting system abnormalities are on average of small immunological risk, substantial maintenance immunosuppression reduction may help to control infections.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






